NFKB1 and neoplasm: These findings reveal a tumor-suppressive role of NIK in pancreatic cancer and underscore the need for caution in targeting NF-κB signaling, as balanced pathway activity appears critical for regulating early tumor progression and microenvironmental interactions in PDAC.